Pradeep Bhadauria
Chief Tech/Sci/R&D Officer at CIPLA LIMITED
Profile
Presently, Pradeep Bhadauria holds the position of Global Chief Scientific Officer at Cipla Ltd. In his past career Mr. Bhadauria was Chief Scientific Officer of Amneal Pharmaceuticals, Inc. Mr. Bhadauria received an undergraduate degree from Shri Govindram Seksaria Institute of Technology & Science and a graduate degree from Birla Institute of Technology & Science.
Pradeep Bhadauria active positions
Companies | Position | Start |
---|---|---|
CIPLA LIMITED | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Former positions of Pradeep Bhadauria
Companies | Position | End |
---|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | - |
Training of Pradeep Bhadauria
Birla Institute of Technology & Science | Graduate Degree |
Shri Govindram Seksaria Institute of Technology & Science | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CIPLA LIMITED | Health Technology |
Private companies | 1 |
---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Pradeep Bhadauria